8 Continuous vs 8 Intermittent Cycles in First and Second Line in HER2/Neu Neg Metastatic Breast Cancer

Clinical trial NCT01935492 · COMPLETED

Trial details

NCT number: NCT01935492
Sponsor: Borstkanker Onderzoek Groep
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Human Epidermal Growth Factor 2 Negative Carcinoma of Breast Metastatic Breast Cancer

Start date: 2010-11-01
Primary completion: 2019-04-01
Enrollment: 420

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.